This restricted production of SMN protein from the SMN2 transcript is pivotal for the survival of SMA patients, with SMN2 gene copy number being a key genetic determinant of SMA severity [26, 27]. This evidence concerns the gene STMN1 and proximal spinal muscular atrophy.